These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8541820)

  • 1. Acute bronchial infection in chronic obstructive pulmonary disease.
    Dorca J
    Monaldi Arch Chest Dis; 1995 Oct; 50(5):366-71. PubMed ID: 8541820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial therapy of acute infectious exacerbation of chronic obstructive pulmonary disease.
    Chelidze K; Jgarkava M
    Georgian Med News; 2008 Jun; (159):27-30. PubMed ID: 18633147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Causative role of infections with viruses or atypical pathogens in acute exacerbations of chronic bronchitis less frequent than expected].
    Roessingh PH; van Loon AM; Lammers JW; Hoepelman IM
    Ned Tijdschr Geneeskd; 1996 Nov; 140(48):2406-10. PubMed ID: 8984413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Administration of acute exacerbation of chronic obstructive pulmonary disease].
    Ito T; Yoshida S
    Nihon Rinsho; 2003 Dec; 61(12):2170-4. PubMed ID: 14674328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchial hyperresponsiveness and bacterial respiratory infections.
    Cazzola M; Matera MG; Rossi F
    Clin Ther; 1991; 13(1):157-71. PubMed ID: 1709390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotic therapy in bronchopulmonary infections].
    Moroni M; Franzetti F; Antinori S
    Ann Ital Med Int; 1992; 7(3 Suppl):86S-93S. PubMed ID: 1297403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of respiratory infection in exacerbation of chronic obstructive pulmonary disease].
    Dacydchenko SV; Bova AA
    Klin Med (Mosk); 2007; 85(5):10-5. PubMed ID: 17665597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branhamella infections. An increasingly common respiratory illness.
    Feleke G; Khan FA
    Postgrad Med; 1989 Mar; 85(4):379-86. PubMed ID: 2494649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Lin SH; Kuo PH; Hsueh PR; Yang PC; Kuo SH
    Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease.
    Diederen BM; van der Valk PD; Kluytmans JA; Peeters MF; Hendrix R
    Eur Respir J; 2007 Aug; 30(2):240-4. PubMed ID: 17459899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infections in chronic obstructive pulmonery disease].
    Leophonte P
    Bull Acad Natl Med; 2004; 188(1):47-64; discussion 64-6. PubMed ID: 15368925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
    Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Respiratory tract infection and acute deterioration of obstructive lung disease].
    Clementsen PS; Kristensen KS; Espersen F; Norn S
    Ugeskr Laeger; 1991 May; 153(19):1336-9. PubMed ID: 2042239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional specifics of microbial landscape in outpatients with lower respiratory tract infections.
    Baturin VA; Shchetinin EV; Malykhin FT
    Int J Risk Saf Med; 2015; 27 Suppl 1():S61-2. PubMed ID: 26639714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).
    Butorac-Petanjek B; Parnham MJ; Popovic-Grle S
    J Chemother; 2010 Oct; 22(5):291-7. PubMed ID: 21123150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
    Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A
    Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe exacerbations of COPD patients: the role of pulmonary infections.
    Fagon JY; Chastre J
    Semin Respir Infect; 1996 Jun; 11(2):109-18. PubMed ID: 8776780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence factors in the colonization and persistence of bacteria in the airways.
    van Alphen L; Jansen HM; Dankert J
    Am J Respir Crit Care Med; 1995 Jun; 151(6):2094-9; discussion 2099-100. PubMed ID: 7767563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection.
    Mogulkoc N; Karakurt S; Isalska B; Bayindir U; Celikel T; Korten V; Colpan N
    Am J Respir Crit Care Med; 1999 Jul; 160(1):349-53. PubMed ID: 10390424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.